Itamar Medical Announces Favorable CMS Reimbursement Decision to its WatchPATTM Sleep Apnea Testing Device
November , 2018
Itamar Medical Ltd. (TASE: ITMR), a company that develops, manufactures, and markets non-invasive diagnostic medical devices for sleep-apnea with a focus on the cardiology market
The new device will enable specific identification and reporting of Central Sleep Apnea (CSA).
Itamar Medical Launches SleePathTM
Innovative e-Health CARDIO SLEEP DASHBOARD provides timely insights into patients’ sleep status and compliance with sleep apnea therapy specially design for cardiologists needs
In light of the growing evidence of the link between cardiovascular disease and obstructive sleep apnea (OSA), Itamar Medical Ltd. (TASE:ITMR) is expanding its business model by offering a comprehensive sleep apnea management solution to cardiologists.